Fritextsökning
Innehållstyper
-
"Are we doing business the wrong way around in the Life Science Sector?"
For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which...
-
Enzymatica ökar försäljningen
Det Lundabaserade bioteknikföretaget Enzymatica redovisar en nettoomsättning på 1,27 miljoner kr under årets andra kvartal. Att jämföra med 0,5 miljoner kr för ...
-
Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages
For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...
-
“We are Europe’s hotspot in life science”
The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees ...
-
Sådan kan du forbedre dit byggefirma
Hvis du har et byggefirma, så giver det god mening, at du ønsker, at det skal være så godt som muligt. Dermed er det kun en fordel, hvis du hele tiden tænker ov...
-
MVA:s CEO: “Our investments should improve people´s everyday lives”
Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.
-
Ready-to-install solutions for the lab-on-a-chip
Design for manufacturing lab-on-a-chip devices Reducing time-to-market together
-
New rules for diagnostic products, but who will certify them? “An extreme shortage area”
In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...
-
Valves with piezo technology
Efficient control and regulation of gases in medical technology
-
Column: "Are we already living in the new normal?"
2020 felt like the year that we were building the house around us whilst moving into it at the same time.
-
New diagnostic test soon ready for the market
-
Sweden and Denmark – this is how they choose their strategies
Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.
-
Lundbeck behind the first EU-approved intravenous migraine treatment
A preventive, intravenous treatment for migraines has been approved in the EU for the first time.
-
Google satsar på diagnostik
Utvecklar sökverktyg för kroppen.
-
Detta är orsaken till at designlampor kostar så mycket
Med den ökade digitalisering kan vi nu köpa allt vi önskar oss på nätet, vilket ställer större krav till traditionella retail-butiker.
-
Sanofi och Google i diabetessamarbete
Tar fram nya instrument för diabetespatienter.
-
Google satsar på life science
Skapar ett nytt bolag med Google X-labbets life science-team.
-
Combining two drug delivery strategies to improve bioavailability
Danish researchers hope to increase the bioavailability of low solubility drugs.
-
Amorphous materials take centre stage when Orexo develops new formulations
Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...
-
FOKUS Patient turns international
FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.
-
Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”
”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...
-
From spin-off to phase II
”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.
-
Googles senaste medtech-satsning
Vill mäta blodsockerhalten i tårvätskan med innovativ kontaktlins.
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...